Effects of leukotriene receptor antagonists on airway remodeling and Th17 cells/CD4+CD25+regulatory T cells expresson in asthma
10.3969/j.issn.1000-3606.2014.08.023
- VernacularTitle:白三烯受体拮抗剂对哮喘气道重塑及Th17细胞/CD4+CD25+调节性T细胞表达的影响
- Author:
Li LI
;
Min LI
- Publication Type:Journal Article
- Keywords:
asthma;
airway remodeling;
leukotriene receptor antagonists;
Th17 cells;
CD4+CD25+treg cells
- From:
Journal of Clinical Pediatrics
2014;(8):789-792
- CountryChina
- Language:Chinese
-
Abstract:
The airway remodeling of bronchial asthma is the result of repeated airway inlfammation. Its occurrence is a complex process involving many cytokines, inlfammatory mediators and associated cellular components, of which leukotrienes are important mediators of inlfammation in the airway remodeling. Many factors inlfuence Airway remodeling. In recent years, effects of Th17 cells and CD4+CD25+regulatory T cells (CD4+CD25+treg cells) on airway remodeling is growing in importance. Leukotriene receptor antagonist is an effective drug in the treatment of asthma and can suppress airway remodeling. But the exact mechanisms and its impact on the proportion of Th17 cells/CD4+CD25+treg cells is not yet clear. Therefore, the clariifcation of the changes of Th17 cells/CD4+CD25+treg cells expression in airway remodeling and the speciifc pathways, biological effects, inlfuence of the proportion of Th17 cells/CD4+CD25+treg cells expression after leukotriene receptor antagonist intervene can provide a new target for prevention and the treatment of asthma in the future.
